US President Donald TrumpUS President Donald TrumpUS President Donald Trump on Monday suggested Pfizer Inc could secure the first US approval of a Covid-19 vaccine in coming weeks, saying a contender by Johnson & Johnson could come later.
Asked which drugmaker could be approved, Trump told Fox News in an interview: "Pfizer's doing really well," adding "Johnson & Johnson ... they'll probably be a little later."
He also cited efforts by Moderna Inc and AstraZeneca Plc.
Also read: Pfizer vaccine early trials bet on win against COVID-19
RBI cuts rates: Edelweiss AMC says short-duration debt funds offer best value now
Putin’s visit to India strengthens bilateral ties with key agreements across sectors. Check details
Earnings cut cycle to resume post Q4 results, warns Aditya Khemka of InCred Asset Management 
IndiGo flight chaos: Bengaluru flights to Delhi, Mumbai cancelled till midnight. Airport issues advisory
IndiGo flights cancellation: 'Schedules expected to start returning to normal by midnight,' says Civil Aviation Ministry
Big RBI Move! ₹1.5 Lakh Crore Liquidity Surplus & Cheaper Loans | 78 bps Rate Drop
Historic! India Records 0.3% Inflation & 8.2% GDP Growth - A Rare Goldilocks Moment
Inflation At Record Low, Growth Outlook Strong, RBI Upgrades India’s GDP Forecast To 7.3%
PM Modi: Despite Global Crises, India–Russia Bond Stands Firm Like A Pole Star |Joint Press Briefing
Rupee at 90: RBI’s Calculated Move? Expert Explains Market Impact
RBI's bold rate cut signals growth focus as Budget nears
Cloudflare outage briefly hits Zerodha, Groww & other servicesEarnings cut cycle to resume post Q4 results, warns Aditya Khemka of InCred Asset Management 
BEML inks MoU for maritime financing after securing two orders in two days 
Sensex up 447 pts, Nifty tops 26,150 as RBI cuts repo rate; will rally continue next week?